| 臺大學術典藏 |
2021-04-29T05:08:53Z |
Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum
|
Liao W.-Y.; Ho C.-C.; Tsai T.-H.; KUAN-YU CHEN; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-04-29T05:08:53Z |
Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery
|
Yang W.-C.; Xiao F.; Shih J.-Y.; Ho C.-C.; Chen Y.-F.; Tseng H.-M.; KUAN-YU CHEN; Liao W.-Y.; Yu C.-J.; Yang J.C.-H.; Kuo S.-H.; Cheng J.C.-H.; Yang P.-C.; Hsu F.-M. |
| 臺大學術典藏 |
2021-04-29T05:08:51Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Lin Y.-T.;Chen J.-S.;Liao W.-Y.;Ho C.-C.;Hsu C.-L.;Yang C.-Y.;Kuan-Yu Chen;Lee J.-H.;Lin Z.-Z.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Lin Y.-T.; Chen J.-S.; Liao W.-Y.; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; KUAN-YU CHEN; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2021-04-29T05:08:51Z |
Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients
|
Yao Z.-H.;Liao W.-Y.;Ho C.-C.;Kuan-Yu Chen;Shih J.-Y.;Chen J.-S.;Lin Z.-Z.;Lin C.-C.;Yang J.C.-H.;Yu C.-J.; Yao Z.-H.; Liao W.-Y.; Ho C.-C.; KUAN-YU CHEN; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2021-04-29T05:08:50Z |
Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors
|
Lee J.-H.;Chen H.-Y.;Hsu F.-M.;Chen J.-S.;Liao W.-Y.;Shih J.-Y.;Yu C.-J.;Kuan-Yu Chen;Tsai T.-H.;Yang J.C.-H.; Lee J.-H.; Chen H.-Y.; Hsu F.-M.; Chen J.-S.; Liao W.-Y.; Shih J.-Y.; Yu C.-J.; KUAN-YU CHEN; Tsai T.-H.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-04-29T05:08:50Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Kuan-Yu Chen;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; KUAN-YU CHEN; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2021-04-29T05:08:48Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Kuan-Yu Chen;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; KUAN-YU CHEN; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2021-04-29T05:08:46Z |
Monitoring levels of vimentin-positive circulating cancer stem cells and tumor cells in patients with advanced EGFR-mutated non-small cell lung cancer
|
Hsu C.-L.; Tsai T.-H.; Huang C.-K.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Ruan S.-Y.; KUAN-YU CHEN; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2021-04-23T05:56:28Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Chih-Hsin Yang;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; CHIH-HSIN YANG; Yu C.-J. |
| 臺大學術典藏 |
2021-03-12T00:50:59Z |
Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy
|
Tsai T.-H.;Yang C.-Y.;Ho C.-C.;Liao W.-Y.;I-Shiow Jan;Chen K.-Y.;Wang J.-Y.;Ruan S.-Y.;Yu C.-J.;Yang J.C.H.;Yang P.-C.;Shih J.-Y.; Tsai T.-H.; Yang C.-Y.; Ho C.-C.; Liao W.-Y.; I-SHIOW JAN; Chen K.-Y.; Wang J.-Y.; Ruan S.-Y.; Yu C.-J.; Yang J.C.H.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2021-03-12T00:50:59Z |
Survival of lung adenocarcinoma patients with malignant pleural effusion
|
Wu S.-G.;Yu C.-J.;Tsai M.-F.;Liao W.-Y.;Yang C.-H.;I-Shiow Jan;Yang P.-C.;Shih J.-Y.; Wu S.-G.; Yu C.-J.; Tsai M.-F.; Liao W.-Y.; Yang C.-H.; I-SHIOW JAN; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2021-03-11T12:03:49Z |
The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancer
|
Yu K.-L.;Tsai T.-H.;Ho C.-C.;Liao W.-Y.;Ching-Kai Lin;Hsu C.-L.;Shih J.-Y.; Yu K.-L.; Tsai T.-H.; Ho C.-C.; Liao W.-Y.; CHING-KAI LIN; Hsu C.-L.; Shih J.-Y. |
| 臺大學術典藏 |
2021-03-11T08:34:19Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang S.-K.;Lee M.-R.;Liao W.-Y.;Ho C.-C.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; MENG-RUI LEE; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y. |
| 臺大學術典藏 |
2021-03-11T08:34:19Z |
Psychological distress and coping strategies among women with incurable lung cancer: a qualitative study
|
Liao Y.-C.;Liao W.-Y.;Sun J.-L.;Jen-Chang Ko;Yu C.-J.; Liao Y.-C.; Liao W.-Y.; Sun J.-L.; JEN-CHANG KO; Chong-Jen Yu |
| 臺大學術典藏 |
2021-03-11T08:29:34Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang S.-K.; Lee M.-R.; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y. |
| 臺大學術典藏 |
2021-03-11T08:29:34Z |
Psychological distress and coping strategies among women with incurable lung cancer: a qualitative study
|
Liao Y.-C.; Liao W.-Y.; Sun J.-L.; JEN-CHANG KO; Yu C.-J. |
| 臺大學術典藏 |
2021-03-11T07:58:29Z |
Psychological distress and coping strategies among women with incurable lung cancer: a qualitative study
|
Liao Y.-C.; Liao W.-Y.; Sun J.-L.; JEN-CHANG KO; Yu C.-J. |
| 臺大學術典藏 |
2021-03-11T07:58:28Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang S.-K.; Lee M.-R.; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y. |
| 臺大學術典藏 |
2021-02-23T08:26:16Z |
Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery
|
Yang W.-C.;Xiao F.;Shih J.-Y.;Ho C.-C.;Chen Y.-F.;Tseng H.-M.;Chen K.-Y.;Liao W.-Y.;Yu C.-J.;Yang J.C.-H.;Sung-Hsin Kuo;Cheng J.C.-H.;Yang P.-C.;Hsu F.-M.; Yang W.-C.; Xiao F.; Shih J.-Y.; Ho C.-C.; Chen Y.-F.; Tseng H.-M.; Chen K.-Y.; Liao W.-Y.; Yu C.-J.; Yang J.C.-H.; SUNG-HSIN KUO; Cheng J.C.-H.; Yang P.-C.; Hsu F.-M. |
| 臺大學術典藏 |
2021-01-15T02:46:20Z |
Prospective evaluation of procalcitonin, soluble triggering receptor expressed on myeloid cells-1 and c-reactive protein in febrile patients with autoimmune diseases
|
Lin C.-H.; SONG-CHOU HSIEH; Keng L.-T.; Lee H.-S.; Chang H.-T.; Liao W.-Y.; Ho C.-C.; Yu C.-J. |
| 臺大學術典藏 |
2021-01-12T03:00:19Z |
The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancer
|
Ho C.-C.; Liao W.-Y.; Lin C.-K.; Hsu C.-L.; Shih J.-Y.; KAI-LUN YU; Tsai T.-H. |
| 臺大學術典藏 |
2021-01-08T03:40:20Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Shih J.-Y.; Ko J.-C.; Ho C.-C.; Liao W.-Y.; Lee M.-R.; SHENG-KAI LIANG |
| 臺大學術典藏 |
2021-01-08T02:56:49Z |
Prospective evaluation of procalcitonin, soluble triggering receptor expressed on myeloid cells-1 and c-reactive protein in febrile patients with autoimmune diseases
|
Lin C.-H.;Hsieh S.-C.;Li-Ta Keng;Lee H.-S.;Chang H.-T.;Liao W.-Y.;Ho C.-C.;Yu C.-J.; Chou-Han Lin; Song-Chou Hsieh; LI-TA KENG; Ho-Sheng Lee; Hou-Tai Chang; Wei-Yu Liao; Chao-Chi Ho; Chong-Jen Yu |
| 國立成功大學 |
2021 |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
|
Huang, Y.-H.;Hung, J.-Y.;Ko, H.-W.;Su, P.-L.;Lai, C.-L.;Chang, H.-C.;Hsia, T.-C.;Lin, S.-H.;Wu, K.-L.;Yang, C.-T.;Su, W.-C.;Chu, Y.-C.;Wang, C.-C.;Liao, W.-Y.;Lin, Y.-T.;Lin, C.-H.;Lin, M.-C.;Hsu, K.-H.;Tseng, J.-S.;Yang, T.-Y.;Chen, K.-C.;Lee, M.-H.;Yu, S.-L.;Ho, C.-C.;Chang, G.-C. |
| 國立成功大學 |
2021 |
A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer
|
Hsu, C.-C.;Liao, W.-Y.;Chang, K.-Y.;Chan, T.-S.;Huang, P.-J.;Chiang, Chiang C.-T.;Shan, Y.-S.;Cheng, L.-H.;Liao, T.-Y.;Tsai, K.K. |
